Biocartis receives FDA approval for Idylla CDx MSI test
First fully automated, cartridge-based companion diagnostic test for colorectal cancer patients approved in the United States
First fully automated, cartridge-based companion diagnostic test for colorectal cancer patients approved in the United States
Tegoprazan, a novel patented molecule indicated for acid-related gastrointestinal diseases, is launched in India under the brand name PCAB
Program provides access to Lilly-trained artificial intelligence to help accelerate breakthrough medicines
The cGMP-4 facility will further strengthen the company's ability to serve global partners
Targeting a 10% reduction in energy and water consumption, and a 30% cut in carbon emissions across facilities by 2025
New unit boosts innovation in liposomal delivery technologies with 8,500 MT capacity and export-ready production
Accelerating RNA-based therapeutic solutions for customers through co-development of products and formulation support
Subscribe To Our Newsletter & Stay Updated